Cargando…

MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis

A major reason for the failure of advanced colorectal cancer (CRC) treatment is the occurrence of chemoresistance to oxaliplatin-based chemotherapy. Recently, studies have shown that long non-coding RNAs (lncRNAs) play an important role in drug resistance. Using HiSeq sequencing methods, we identifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lixia, Shang, Jian, Zhang, Yupeng, Liu, Shi, Peng, Yanan, Zhou, Zhou, Pan, Huaqing, Wang, Xiaobing, Chen, Lipng, Zhao, Qiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549059/ https://www.ncbi.nlm.nih.gov/pubmed/28731151 http://dx.doi.org/10.3892/or.2017.5828

Ejemplares similares

Hypermethylation of lncRNA MEG3 impairs chemosensitivity of breast cancer cells
por: Li, Hongchang, et al.
Publicado: (2020)

Proteomic analysis of the chemosensitizing effect of curcumin on CRC cells treated with 5-FU
por: Yang, Jingbo, et al.
Publicado: (2022)

MACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression
por: Duan, Jiangman, et al.
Publicado: (2017)

The expression of NLK is functionally associated with colorectal cancers (CRC)
por: Chen, Xinyan, et al.
Publicado: (2021)

Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis
por: Lin, Jin-Fei, et al.
Publicado: (2022)

High-Grade Inflammation Attenuates Chemosensitivity and Confers to Poor Survival of Surgical Stage III CRC Patients
por: Ying, Hou-Qun, et al.
Publicado: (2021)

AURKA Increase the Chemosensitivity of Colon Cancer Cells to Oxaliplatin by Inhibiting the TP53-Mediated DNA Damage Response Genes
por: Shan, Baocong, et al.
Publicado: (2020)

Effects of taxol resistance gene 1 expression on the chemosensitivity of SGC-7901 cells to oxaliplatin
por: LIU, LIANCHENG, et al.
Publicado: (2016)

LPS Enhances the Chemosensitivity of Oxaliplatin in HT29 Cells via GSDMD-Mediated Pyroptosis
por: Wu, Li-Sha, et al.
Publicado: (2020)

Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study
por: Amatu, Alessio, et al.
Publicado: (2022)

MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy
por: Jin, Fangfang, et al.
Publicado: (2017)

Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine
por: Rivera, Maria, et al.
Publicado: (2020)

First-line bevacizumab and capecitabine–oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study
por: Feliu, J, et al.
Publicado: (2014)

miR‐129‐2 upregulation induces apoptosis and promotes NSCLC chemosensitivity by targeting SOX4
por: Zhou, Weizheng, et al.
Publicado: (2022)

Attenuation of STAT3 Phosphorylation Promotes Apoptosis and Chemosensitivity in Human Osteosarcoma Induced by Raddeanin A
por: Wang, Zhuoying, et al.
Publicado: (2019)

LY-294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF-1α pathway
por: Xu, Ruyue, et al.
Publicado: (2021)

Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer
por: Liu, Tong, et al.
Publicado: (2019)

Overexpression of Lin28 Decreases the Chemosensitivity of Gastric Cancer Cells to Oxaliplatin, Paclitaxel, Doxorubicin, and Fluorouracil in Part via microRNA-107
por: Teng, Rongyue, et al.
Publicado: (2015)

Oxaliplatin related lncRNAs prognostic models predict the prognosis of patients given oxaliplatin-based chemotherapy
por: Zhou, Qing-nan, et al.
Publicado: (2023)

LncRNA MEG3 promotes chemosensitivity of osteosarcoma by regulating antitumor immunity via miR-21-5p/p53 pathway and autophagy
por: Huang, Xin, et al.
Publicado: (2021)

Correction to: Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer
por: Liu, Tong, et al.
Publicado: (2020)

The effects of ERCC1 expression levels on the chemosensitivity of gastric cancer cells to platinum agents and survival in gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy
por: LIU, YONG-PING, et al.
Publicado: (2013)

miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer
por: Karaayvaz, M, et al.
Publicado: (2013)

Pristimerin Causes G1 Arrest, Induces Apoptosis, and Enhances the Chemosensitivity to Gemcitabine in Pancreatic Cancer Cells
por: Wang, Yongwei, et al.
Publicado: (2012)

A Novel Prognostic Score Based on ZG16 for Predicting CRC Survival
por: Wang, Wei, et al.
Publicado: (2020)

Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis
por: Zarate, R, et al.
Publicado: (2010)

PPP1R12A Copy Number Is Associated with Clinical Outcomes of Stage III CRC Receiving Oxaliplatin-Based Chemotherapy
por: Zhang, Chenbo, et al.
Publicado: (2015)

Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen
por: Martínez-Lago, Nieves, et al.
Publicado: (2022)

MIR600HG suppresses metastasis and enhances oxaliplatin chemosensitivity by targeting ALDH1A3 in colorectal cancer
por: Yao, Yi, et al.
Publicado: (2020)

Retraction Note: Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer
por: Liu, Tong, et al.
Publicado: (2022)

SRPK1/AKT axis promotes oxaliplatin-induced anti-apoptosis via NF-κB activation in colon cancer
por: Huang, Jing-Qiang, et al.
Publicado: (2021)

RAMS11 promotes CRC through mTOR-dependent inhibition of autophagy, suppression of apoptosis, and promotion of epithelial-mesenchymal transition
por: Islam Khan, Md Zahirul, et al.
Publicado: (2021)

The requirement for freshly isolated human colorectal cancer (CRC) cells in isolating CRC stem cells
por: Fan, F, et al.
Publicado: (2015)

Hypermethylation of MEG3 promoter correlates with inactivation of MEG3 and poor prognosis in patients with retinoblastoma
por: Gao, Yali, et al.
Publicado: (2017)

Dexamethasone affects cell growth/apoptosis/chemosensitivity of colon cancer via glucocorticoid receptor α/NF-κB
por: He, Jianming, et al.
Publicado: (2017)

MEG3 regulates apoptosis of adipose-derived stem cells
por: Shi, Yao
Publicado: (2020)

lncRNA MEG8 is downregulated in osteoarthritis and regulates chondrocyte cell proliferation, apoptosis and inflammation
por: Xie, Wei, et al.
Publicado: (2021)

DOCK4 Is a Platinum-Chemosensitive and Prognostic-Related Biomarker in Ovarian Cancer
por: Zhao, Qianqian, et al.
Publicado: (2021)

MPC1 Deficiency Promotes CRC Liver Metastasis via Facilitating Nuclear Translocation of β-Catenin
por: Tian, Guang-Ang, et al.
Publicado: (2020)

CRC handbook of microbiology
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_etchfpo3dkdlttqkk0rpsabou9